| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 30,347 | 32,625 | 23,690 | | Cost of Revenue | 21,164 | 19,706 | 14,313 | | | Gross Profit | 9,184 | 12,919 | 9,377 | | | Operating Expenses | | Research Development | 1,869 | 1,018 | 782 | | Selling General and Administrative | 7,899 | 7,589 | 5,684 | | Non Recurring | 9,260 | (90) |
-
| | Others | 566 | 733 | 752 | | | | Total Operating Expenses | 19,593 | 9,250 |
-
| | | | Operating Income or Loss | (10,410) | 3,669 | 2,159 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52 | (170) | 273 | | Earnings Before Interest And Taxes | (10,357) | 3,499 | 2,432 | | Interest Expense | 380 | 485 | 429 | | Income Before Tax | (10,738) | 3,013 | 2,003 | | Income Tax Expense | (1,174) | 1,351 | 962 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,564) | 1,662 | 1,041 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,564) | 1,662 | 1,041 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,564) | $1,662 | $1,041 |
|
0.34% Nasdaq 
0.20 (6.23%) 
Income Statement
